166 related articles for article (PubMed ID: 36506092)
1. A prognostic model for patients with primary extramedullary multiple myeloma.
Zhang L; Chen S; Wang W; Wang Y; Liang Y
Front Cell Dev Biol; 2022; 10():1021587. PubMed ID: 36506092
[No Abstract] [Full Text] [Related]
2. Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma.
He J; Yue X; He D; Zhao Y; Yang Y; Zheng G; Zhang E; Han X; Wu W; Yang L; Chen J; Cai Z
Front Oncol; 2021; 11():668099. PubMed ID: 34307138
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
[TBL] [Abstract][Full Text] [Related]
4. Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.
Cheng Q; Zhao F; Zhang B; Zhang Y; Cai L; Qiao B; Hu Y; Sun C
Int Immunopharmacol; 2021 Oct; 99():108016. PubMed ID: 34385029
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory and Nutritional Scoring System for Predicting Prognosis in Patients with Newly Diagnosed Multiple Myeloma.
Zhang L; Chen S; Wang W; Wang Y; Liang Y
J Inflamm Res; 2023; 16():7-17. PubMed ID: 36636247
[TBL] [Abstract][Full Text] [Related]
6. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
7. Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience.
Hou ZL; Kang Y; Yang GZ; Wang Z; Wang F; Yu YX; Chen WM; Shi HZ
Ann Hematol; 2021 Jul; 100(7):1789-1801. PubMed ID: 33715037
[TBL] [Abstract][Full Text] [Related]
8. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
9. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
10. Survival trends and prognostic factors of patients with newly diagnosed multiple myeloma accompanied with extramedullary disease.
Wang J; Shen N; Shen X; Zhang R; Jin Y; Li J; Chen L
Ann Med; 2023; 55(2):2281657. PubMed ID: 38086395
[No Abstract] [Full Text] [Related]
11. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma.
Zhang Y; Chen XL; Chen WM; Zhou HB
Biomed Res Int; 2019; 2019():5652935. PubMed ID: 31080823
[TBL] [Abstract][Full Text] [Related]
13. Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials.
Que Y; Xu M; Xu Y; Almeida VDF; Zhu L; Wang Z; Wang Y; Liu X; Jiang L; Wang D; Li C; Zhou J
Front Immunol; 2021; 12():755866. PubMed ID: 34777368
[TBL] [Abstract][Full Text] [Related]
14. A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy.
Wang N; Xi W; Lu S; Jiang J; Wang C; Zhu Z; Yan C; Liu J; Zhang J
Front Oncol; 2021; 11():650562. PubMed ID: 34195071
[TBL] [Abstract][Full Text] [Related]
15. Integration of clinical features and sociodemographic factors: a simplified prognostic model for patients with multiple myeloma based on a double-center retrospective analysis.
Xu J; Wang R; Han Q; Zuo Y; Sun J; Chen B; Dong X
Am J Cancer Res; 2023; 13(3):1038-1048. PubMed ID: 37034202
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and outcomes of patients newly diagnosed with multiple myeloma with extramedullary disease].
Wang J; Zhang LN; Shi QL; Qu XY; Chen LJ; Li JY; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):822-828. PubMed ID: 33190439
[No Abstract] [Full Text] [Related]
17. Interaction between age and gender on survival outcomes in extramedullary multiple myeloma over the past two decades.
Bangolo AI; Fwelo P; Trivedi C; Sagireddy S; Aljanaahi H; Auda A; Mohamed M; Onyeka S; Fisher M; Thapa J; Tabucanon EJ; Georgiev L; Wishart A; Kumari S; Erikson C; Bangura M; Paddy O; Madhukar R; Gomez EL; Rathod J; Naria M; Hajal B; Awadhalla M; Siegel D; Parmar H; Biran N; Vesole DH; Phull P; Weissman S
World J Clin Oncol; 2023 Apr; 14(4):179-189. PubMed ID: 37124133
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study.
Tong Y; Cui Y; Jiang L; Pi Y; Gong Y; Zhao D
Front Public Health; 2022; 10():901680. PubMed ID: 35844853
[TBL] [Abstract][Full Text] [Related]
19. Nomogram for predicting overall survival in stage II-III colorectal cancer.
Liu J; Huang X; Yang W; Li C; Li Z; Zhang C; Chen S; Wu G; Xie W; Wei C; Tian C; Huang L; Jeen F; Mo X; Tang W
Cancer Med; 2020 Apr; 9(7):2363-2371. PubMed ID: 32027098
[TBL] [Abstract][Full Text] [Related]
20. A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.
Shang X; Yu H; Lin J; Li Z; Zhao C; Sun J; Wang H
J Oncol; 2020; 2020():7863984. PubMed ID: 32565807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
